Proteome Sciences (LON:PRM) Stock Price Down 27.2% – Here’s What Happened

Proteome Sciences plc (LON:PRM) was down 27.2% during trading on Monday . The company traded as low as GBX 1.66 and last traded at GBX 2.30. Approximately 328,570 shares changed hands during mid-day trading, an increase of 0% from the average daily volume of 327,618 shares. The stock had previously closed at GBX 3.16.

Proteome Sciences Stock Down 2.3%

The firm’s 50 day simple moving average is GBX 2.45 and its 200-day simple moving average is GBX 2.53. The company has a market cap of £5.64 million, a price-to-earnings ratio of -1.69 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.